The FDA today announced that it issued emergency use authorization (EUA) for Acon Laboratories’ Flowflex COVID-19 home test. Authorization of the antigen test should significantly increase the availability of rapid, at-home tests, director of FDA’s Center for Devices and Radiological Health Dr. Jeff Shuren said in a statement. The agency expects fast, at-home testing capacity […]
Innovus Pharmaceuticals (OTC:INNV) announced today that it has inked an agreement with its current partner, Acon Laboratories, to sell Acon’s FDA-cleared glucose monitor, test strips and lancet device. The San Diego, Calif.-based company plans to sell Acon’s glucose testing kit with its GlucoGorx glucose supplement. Get the full story at our sister site, Drug Delivery Business News.